Alphatec Holdings Inc. (ATEC), a medical equipment and supplies holding company, saw its stock soar 6.69% in pre-market trading on Thursday. This surge came after the company reported robust financial results for the fourth quarter of 2024 and provided an optimistic outlook for 2025.
In the fourth quarter, Alphatec achieved total revenue of $177 million, a remarkable 28% year-over-year increase and 17% sequential growth. The company's surgical revenue grew by 28% year-over-year to $157 million, while its EOS revenue rose by 32% to $20 million. Alphatec also reported positive free cash flow of $9 million for the first time since its transformation.
Looking ahead, Alphatec provided an optimistic revenue outlook for 2025, projecting approximately $732 million in revenue, representing a 20% growth rate. The company also forecasted an adjusted EBITDA of $75 million for the upcoming year. These positive financial projections, coupled with the strong fourth-quarter performance, likely fueled investor confidence and drove the pre-market surge in Alphatec's stock price.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。